(Q47865465)

6 February 2018

title

High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. (English)

1 reference

6 February 2018

main subject

Plasmodium falciparum

1 reference

7

Druilhe P

1 reference

6 February 2018

author name string

Benmohamed L

1

1 reference

6 February 2018

Thomas A

2

1 reference

6 February 2018

Bossus M

3

1 reference

6 February 2018

Brahimi K

4

1 reference

6 February 2018

Wubben J

5

1 reference

6 February 2018

Gras-Masse H

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

6 February 2018

published in

Vaccine

1 reference

6 February 2018

volume

18

1 reference

6 February 2018

issue

25

1 reference

6 February 2018

page(s)

2843-2855

1 reference

6 February 2018

Malaria disaster in Africa

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Impact of chloroquine resistance on malaria mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Protection against malaria induced by irradiated sporozoites.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Chimpanzees and supporting models in the study of malaria pre-erythrocytic stages.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Human T Cell Antigen Expression by Primate T Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Plasmodium falciparum: studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Pimelautide or trimexautide as built-in adjuvants associated with an HIV-1-derived peptide: synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocyte-mediated response.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

The mixotope: a combinatorial peptide library as a T cell and B cell immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Fast immunopurification of small amounts of specific antibodies on peptides bound to ELISA plates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Determination of B-cell epitopes of nef HIV-I protein: immunogenicity related to their structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Local protein instability predictive of helper T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Enhancement of peptide antigen presentation by a second peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900068-2

7 January 2021

10.1016/S0264-410X(00)00068-2

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

10812228

1 reference

6 February 2018